|
|
|
| Impact of chronic diseases management on the quality of life of patients with benign prostatic hyperplasia |
| MA Zhengjun SUN Xiaohong |
| Department of Urology, Beijing Geriatric Hospital, Beijing 100095, China |
|
|
|
Abstract Objective To explore the effect of chronic diseases management mode on quality of life of the patients with benign prostatic hyperplasia, so as to provide references for effective development of health education of benign prostatic hyperplasia. Methods A total of 200 patients(≥65 years old) were investigated from May 2011 to April 2012 in Beijing Geriatric Hospital, stratified randomly divided into normal mode group(n=100) and management mode group(n=100), the normal group received routine diagnosis and health education, and the chronic diseases management group received the hospital-community-message unify platform. After 5 years, international prostate symptom score (IPSS), quality of life and urinary retention were compared between the two groups after 5 years of follow-up. Results IPSS of chronic diseases management group was better than the normal mode group, and the difference was statistically significant (Z = 2.031, P < 0.05). The QOL scores in the two groups was less than that befores intervention, and the difference was statistically significant (t = 2.283, P < 0.05; t =3.908, P < 0.05), and the QOL scores of the chronic diseases management group was lower than that of the normal model group, the difference was statistically significant (t = 2.587, P < 0.05). The incidence rate of urinary retention in chronic disease management group was 6%, the incidence rate in normal group was 22%, the incidence rate between the two groups was statistically significant (χ2 = 11.368, P ＜ 0.05). Conclusion Chronic disease management mode is especially important for health management of patients with benign prostatic hyperplasia, which not only can effectively control symptoms, but also reduce the incidence of urinary retention and improve the quality of life of patients.
|
|
|
|
|
|
[1] 梁秀山.良性前列腺增生症的治疗现状[J].中国医药导报，2010，7（23）：12-14.
[2] 汤如，刘淼，宗文漪，等.某医院老年男性体检人群主要慢性病的疾病谱与检出率分析[J].中华老年多器官疾病杂志，2017，16（2）：124-127.
[3] 王光荣，余国芳.社区老年人良性前列腺增生相关影响因素分析[J].中国实用医药，2017，12（28）：28-30.
[4] Wei JT，Calhoun E，Jacobsen SJ. Urologic diseases in America project： benign prostatic hyperplasia [J]. J Urol，2005， 173（3）：933-937.
[5] 叶瑞香.社区高血压慢病管理模式改善高龄EH患者疗效及对血压变异性的影响[J].中国实用医药，2018，13（1）：144-145.
[6] 熊波，简铭，王晓明，等.基于医院-社区-家庭-个人的慢阻肺慢病管理模式探讨[J].中国社区医师，2017，33（21）：6-7.
[7] 金芳芳，余爱萍.慢病管理模式在慢性粒细胞白血病患者疾病管理中的应用[J].现代实用医学，2016，28（2）：246-248.
[8] 陆萍，宋玮，宋道平.慢病照护模式在社区高血压前期患者的实施与评价[J].实用预防医学，2016，23（3）：295-298.
[9] 叶章群.良性前列腺增生的诊断和治疗[J].中华老年医学杂志，2006，25（5）：390-392.
[10] 吴阶平.吴阶平泌尿外科学[M].山东：山东科学技术出版社，2017，268，1143-1155.
[11] 刘明，王建业，于普林，等.中国11城市老年科门诊良性前列腺增生现状调查[J].中华老年医学杂志，2009， 28（7）：597-601.
[12] 程威，唐根富.良性前列腺增生患者的生活质量研究[J].现代预防医学，2008，35（23）：4623-4624.
[13] 孟华，郭雨禾，郭建英，等.军队离休干部慢病现状及管理模式探索[J].中华保健医学杂志，2016，18（6）：501-502，505.
[14] 刘月星，宗文红，王伟，等.基于慢病管理模式的新型慢病管理模式应用的SWOT分析[J].中国全科医学，2013， 16（34）：4078-4080.
[15] 杨海涛，吕志国，张影，等.国内慢病管理的研究现状[J].中国社区医师，2014，30（10）：147-148.
[16] 王维民，程刚，谢杰，等.强化医院慢病管理服务的实践[J].中国医院，2017，21（3）：79-80.
[17] 黄燕波，于书慧，车新艳.前列腺增生患者生活质量与临床症状的相关性分析[J].中华现代护理杂志，2015， 21（3）：306-308.
[18] 汪苗，邢彩霞.新医改背景下城市慢病健康管理问题探析[J].医学与哲学，2017，38（4）：87-90.
[19] 贺婷，刘星，李莹，等.大数据分析在慢病管理中应用研究进展[J].中国公共卫生，2016，32（7）：981-984. |
|
|
|
